Cara Therapeutic Stock Investor Sentiment

CARA Stock  USD 0.29  0.01  3.33%   
About 67% of Cara Therapeutic's investor base is looking to short. The analysis of overall sentiment of trading Cara Therapeutic stock suggests that many investors are alarmed at this time. The current market sentiment, together with Cara Therapeutic's historical and current headlines, can help investors time the market. In addition, many technical investors use Cara Therapeutic stock news signals to limit their universe of possible portfolio assets.
  

Cara Therapeutic Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Cara Therapeutic can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over six months ago at gurufocus.com         
Acquisition by Jeffrey Ives of 16996 shares of Cara Therapeutic subject to Rule 16b-3
Gurufocus Stories at Macroaxis
over six months ago at news.google.com         
Where Will Cara Therapeutics Inc Stock Go Next After It Has Fallen 9.89 percent in a Week - Investor...
Google News at Macroaxis
over six months ago at finance.yahoo.com         
SWK Holdings Corporation Announces Financial Results for Fourth Quarter 2023
Yahoo News
over six months ago at finance.yahoo.com         
Disposition of 2481 shares by Scott Terrillion of Cara Therapeutic at 4.91 subject to Rule 16b-3
Yahoo News
over six months ago at thelincolnianonline.com         
Cara Therapeutics Earns Buy Rating from Needham Company LLC
news
over six months ago at finance.yahoo.com         
Analysts Have Made A Financial Statement On Cara Therapeutics, Inc.s Yearly Report
Yahoo News
over six months ago at finance.yahoo.com         
Cara Therapeutics to Host Notalgia Paresthetica Virtual KOL Event on Wednesday, March 27, 2024
Yahoo News
over six months ago at benzinga.com         
Cara Therapeutics to Host Notalgia Paresthetica Virtual KOL Event on Wednesday, March 27, 2024
benzinga news
over six months ago at finance.yahoo.com         
Cara Therapeutics Full Year 2023 Earnings Misses Expectations
Yahoo News
over six months ago at thelincolnianonline.com         
Cara Therapeutics Price Target Cut to 10.00
news
over six months ago at thelincolnianonline.com         
Cara Therapeutics Releases Earnings Results, Misses Expectations By 0.02 EPS
news
over six months ago at investing.com         
Earnings call Cara Therapeutics focuses on notalgia paresthetica amid challenges
Investing News at Macroaxis
over six months ago at finance.yahoo.com         
Cara Therapeutics, Inc. Q4 2023 Earnings Call Transcript
Yahoo News
over six months ago at investorplace.com         
CARA Stock Earnings Cara Therapeutics Misses EPS, Misses Revenue for Q4 2023
sbwire news
over six months ago at insidermonkey.com         
Cara Therapeutics, Inc. Q4 2023 Earnings Call Transcript
insidermonkey News
Far too much social signal, news, headlines, and media speculation about Cara Therapeutic that are available to investors today. That information is available publicly through Cara media outlets and privately through word of mouth or via Cara internal channels. However, regardless of the origin, that massive amount of Cara data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Cara Therapeutic news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Cara Therapeutic relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Cara Therapeutic's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Cara Therapeutic alpha.

Cara Therapeutic Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Wall Street SWOT Cara Therapeutics stock navigates pivotal phase in drug development - Investing.com
09/27/2024
2
Disposition of 2483 shares by Scott Terrillion of Cara Therapeutic at 3.51 subject to Rule 16b-3
10/28/2024
3
Disposition of 3668 shares by Christopher Posner of Cara Therapeutic at 0.29 subject to Rule 16b-3
11/04/2024
4
Cara Therapeutics CEO Posner sells shares worth 1,063
11/06/2024
5
Cara Q3 Earnings Snapshot
11/15/2024

Complementary Tools for Cara Stock analysis

When running Cara Therapeutic's price analysis, check to measure Cara Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cara Therapeutic is operating at the current time. Most of Cara Therapeutic's value examination focuses on studying past and present price action to predict the probability of Cara Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cara Therapeutic's price. Additionally, you may evaluate how the addition of Cara Therapeutic to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Commodity Directory
Find actively traded commodities issued by global exchanges